Blankstein, Ron

Role of Coronary Artery Calcium Score of Zero and Other Negative Risk Markers for Cardiovascular Disease: The Multi-Ethnic Study of Atherosclerosis (MESA)

Blaha, M. J., Cainzos-Achirica, M., Greenland, P., McEvoy, J. W., Blankstein, R., Budoff, M. J., Dardari, Z., Sibley, C. T., Burke, G. L., Kronmal, R. A., et al. (2016) · Circulation

Cardiac Imaging and DiagnosticsCardiovascular Health and Disease Prevention

Cited by 485

Visceral Adiposity and the Risk of Metabolic Syndrome Across Body Mass Index

Shah, R. V., Murthy, V. L., Abbasi, S. A., Blankstein, R., Kwong, R. Y., Goldfine, A. B., Jerosch-Herold, M., Lima, J. A. C., Ding, J., & Allison, M. A. (2014) · JACC: Cardiovascular Imaging

Cardiovascular Disease and AdiposityDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 427

National Trends in Statin Use and Expenditures in the US Adult Population From 2002 to 2013: Insights From the Medical Expenditure Panel Survey

Salami, J. A., Warraich, H., Valero-Elizondo, J., Spatz, E. S., Desai, N. R., Rana, J. S., Virani, S. S., Blankstein, R., Khera, A., Blaha, M. J., et al. (2017) · JAMA Cardiology

Lipoproteins and Cardiovascular HealthPharmaceutical Economics and Policy

Cited by 370

2026 ACC/AHA/AACVPR/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Dyslipidemia

Blumenthal, R. S., Morris, P. B., Gaudino, M., Johnson, H. M., Anderson, T. S., Bittner, V. A., Blankstein, R., Brewer, L. C., Cho, L., de Ferranti, S. D., et al. (2026) · JACC

Lipoproteins and Cardiovascular HealthDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 304

3D printing based on cardiac CT assists anatomic visualization prior to transcatheter aortic valve replacement

Ripley, B., Kelil, T., Cheezum, M. K., Goncalves, A., Di Carli, M. F., Rybicki, F. J., Steigner, M., Mitsouras, D., & Blankstein, R. (2016) · Journal of Cardiovascular Computed Tomography

Cardiac Valve Diseases and TreatmentsAnatomy and Medical Technology

Cited by 205

The Identification of Calcified Coronary Plaque Is Associated With Initiation and Continuation of Pharmacological and Lifestyle Preventive Therapies

Gupta, A., Lau, E., Varshney, R., Hulten, E. A., Cheezum, M., Bittencourt, M. S., Blaha, M. J., Wong, N. D., Blumenthal, R. S., Budoff, M. J., et al. (2017) · JACC: Cardiovascular Imaging

Cardiac Imaging and DiagnosticsHealth Promotion and Cardiovascular Prevention

Cited by 181

Effect of Sleep Apnea and Continuous Positive Airway Pressure on Cardiac Structure and Recurrence of Atrial Fibrillation

Neilan, T. G., Farhad, H., Dodson, J. A., Shah, R. V., Abbasi, S. A., Bakker, J. P., Michaud, G. F., van der Geest, R., Blankstein, R., Steigner, M., et al. (2013) · Journal of the American Heart Association

Atrial Fibrillation Management and OutcomesObstructive Sleep Apnea Research

Cited by 158

2026 ACC/AHA/AACVPR/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Dyslipidemia: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines

Writing Committee Members, Blumenthal, R. S., Morris, P. B., Gaudino, M., Johnson, H. M., Anderson, T. S., Bittner, V. A., Blankstein, R., Brewer, L. C., Cho, L., et al. (2026) · Circulation

Lipoproteins and Cardiovascular HealthDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 122

Implications of Coronary Artery Calcium Testing for Treatment Decisions Among Statin Candidates According to the ACC/AHA Cholesterol Management Guidelines

Hong, J. C., Blankstein, R., Shaw, L. J., Padula, W. V., Arrieta, A., Fialkow, J. A., Blumenthal, R. S., Blaha, M. J., Krumholz, H. M., & Nasir, K. (2017) · JACC: Cardiovascular Imaging

Lipoproteins and Cardiovascular HealthCardiac Imaging and Diagnostics

Cited by 101

Sarcoidosis-Related Cardiomyopathy: Current Knowledge, Challenges, and Future Perspectives State-of-the-Art Review

Gilotra, N. A., GRIFFIN, J. M., PAVLOVIC, N., HOUSTON, B. A., CHASLER, J., GOETZ, C., CHRISPIN, J., SHARP, M., KASPER, E. K., CHEN, E. S., et al. (2022) · Journal of Cardiac Failure

Sarcoidosis and Beryllium Toxicity ResearchHistiocytic Disorders and Treatments

Cited by 94

Practical, evidence-based approaches to nutritional modifications to reduce atherosclerotic cardiovascular disease: an American Society for Preventive Cardiology Clinical Practice Statement

Belardo, D., Michos, E. D., Blankstein, R., Blumenthal, R. S., Ferdinand, K. C., Hall, K., Klatt, K., Natajaran, P., Ostfeld, R. J., Reddy, K., et al. (2022) · American Journal of Preventive Cardiology

Nutritional Studies and DietCardiovascular Health and Risk Factors

Cited by 90

Polypill Therapy, Subclinical Atherosclerosis, and Cardiovascular Events—Implications for the Use of Preventive Pharmacotherapy

Bittencourt, M. S., Blaha, M. J., Blankstein, R., Budoff, M., Vargas, J. D., Blumenthal, R. S., Agatston, A. S., & Nasir, K. (2014) · Journal of the American College of Cardiology

Cardiac Imaging and DiagnosticsLipoproteins and Cardiovascular Health

Cited by 70

Favorable Cardiovascular Risk Profile Is Associated With Lower Healthcare Costs and Resource Utilization: The 2012 Medical Expenditure Panel Survey

Valero-Elizondo, J., Salami, J. A., Ogunmoroti, O., Osondu, C. U., Aneni, E. C., Malik, R., Spatz, E. S., Rana, J. S., Virani, S. S., Blankstein, R., et al. (2016) · Circulation: Cardiovascular Quality and Outcomes

Cardiovascular Health and Risk FactorsHealth Promotion and Cardiovascular Prevention

Cited by 51

Correction to: 2026 ACC/AHA/AACVPR/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Dyslipidemia: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines

Blumenthal, R. S., Morris, P. B., Gaudino, M., Johnson, H. M., Anderson, T. S., Bittner, V. A., Blankstein, R., Brewer, L. C., Cho, L., de Ferranti, S. D., et al. (2026) · Circulation

Lipoproteins and Cardiovascular HealthClinical practice guidelines implementation

Cited by 48

Nondietary cardiovascular health metrics with patient experience and loss of productivity among US adults without cardiovascular disease: the medical expenditure panel survey 2006 to 2015

Tibuakuu, M., Okunrintemi, V., Savji, N., Stone, N. J., Virani, S. S., Blankstein, R., Thamman, R., Blumenthal, R. S., & Michos, E. D. (2020) · Journal of the American Heart Association

Cardiovascular Health and Risk FactorsHealth Promotion and Cardiovascular Prevention

Cited by 20

Favorable cardiovascular risk factor profile is associated with lower healthcare expenditure and resource utilization among adults with diabetes mellitus free of established cardiovascular disease: 2012 Medical Expenditure Panel Survey (MEPS)

Feldman, D. I., Valero-Elizondo, J., Salami, J. A., Rana, J. S., Ogunmoroti, O., Osondu, C. U., Spatz, E. S., Virani, S. S., Blankstein, R., Blaha, M. J., et al. (2017) · Atherosclerosis

Diabetes, Cardiovascular Risks, and LipoproteinsHealth Promotion and Cardiovascular Prevention

Cited by 11